The DOI matches its Crossref record; 130 of the 130 references it cites were found in a registry or an index.
High-throughput functional genomics using CRISPR-Cas9
Open accessAbstract
Forward genetic screens are powerful tools for the discovery and functional annotation of genetic elements. Recently, the RNA-guided CRISPR (clustered regularly interspaced short palindromic repeat)-associated Cas9 nuclease has been combined with genome-scale guide RNA libraries for unbiased, phenotypic screening. In this Review, we describe recent advances using Cas9 for genome-scale screens, including knockout approaches that inactivate genomic loci and strategies that modulate transcriptional activity. We discuss practical aspects of screen design, provide comparisons with RNA interference (RNAi) screening, and outline future applications and challenges.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the deficiencies of RNAi-based methods in the areas of reagent fidelity and scalability make it difficult to use this approach to accurately map drug target interactions across a large matrix of cell lines and drug treatments”
From A Landscape of Therapeutic Cooperativity in KRAS Mutant Cancers Reveals Principles for Controlling Tumor Evolution (2017) · cites this paper as Shalem et al., 2015
Experimental — accuracy not yet measuredIn the citing paper
“This has limited pooled screens largely to vetting genes for their potential impact on cell fitness”
From Protein Barcodes Enable High-Dimensional Single-Cell CRISPR Screens (2018) · cites this paper as Shalem et al., 2015
In the citing paper
“So far three distinct bacterial CRISPR systems have been identified; Type I, II and III, and it is the Type II system that has mainly been adapted for use in artificial gene regulation and genome editing (Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
In the citing paper
“The most commonly used CRISPR Type II system consists of a gRNA and an endonuclease, the CRISPR-associated (Cas) nuclease, Cas9, which cleaves the targeted chromosomal DNA in a site-specific manner triggering endogenous DNA repair systems resulting in genome modification (for an in-depth review, see Doudna and Charpentier 2014; Kim and Kim 2014; Shalem, Sanjana and Zhang 2015).”
From Candida glabrata : new tools and technologies—expanding the toolkit (2015) · cites this paper as Shalem, Sanjana and Zhang 2015
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans
Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A., Driver, S. E., & Mello, C. C. (1998) · Nature · doi:10.1038/35888 · Cited by 15,429
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Self-citationRNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
MicroRNAs: small RNAs with a big role in gene regulation
He, L., & Hannon, G. J. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1379 · Cited by 7,118
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Self-citationImproved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Self-citationGenome-scale CRISPR-Cas9 knockout screening in human cells
Shalem, O., Sanjana, N. E., Hartenian, E., Shi, X., Scott, D. A., Mikkelsen, T. S., Heckl, D., Ebert, B. L., Root, D. E., Doench, J. G., et al. (2014) · Science · doi:10.1126/science.1247005 · Cited by 5,234
Self-citationRepurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,000
Rao, C., Huisman, D. H., Vieira, H. M., Frodyma, D. E., Neilsen, B. K., Chakraborty, B., Hight, S. K., White, M. A., Fisher, K. W., & Lewis, R. E. (2020) · Cancers · doi:10.3390/cancers12113143 · Cited by 8
A machine learning approach predicts essential genes and pharmacological targets in cancerPreprint
Gilvary, C. M., Madhukar, N. S., Gayvert, K. M., Foronda, M., Perez, A. R., Leslie, C. S., Dow, L. E., Pandey, G. S., & Elemento, O. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/692277 · Cited by 8
Tahoe-100M: Mapping drug-induced molecular phenotypes at single-cell resolution
Zhang, J. M., Ubas, A. A., Svensson, V., Thomas, N., Subramanyam, V., Carpenter, C., Winters, A. F., de Borja, R., Teyssier, N., Thakar, N., et al. (2026) · Cell · doi:10.1016/j.cell.2026.08.035 · Cited by 10
Vredevoogd, D. W., Apriamashvili, G., & Peeper, D. S. (2021) · Immuno-Oncology Technology · doi:10.1016/j.iotech.2021.100043 · Cited by 7
Chemical genetic approaches for the discovery of bacterial cell wall inhibitors
Gupta, R., Singh, M., & Pathania, R. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00143a · Cited by 7
Cheminformatics and Bioinformatics at the Interface with Systems Biology
Kaushik, A. C., Mehmood, A., Wei, D., Nawab, S., Sahi, S., & Kumar, A. (2023) · Royal Society of Chemistry eBooks · doi:10.1039/9781839166037 · Cited by 7
Liu, L., Yin, Y.-Q., Ma, K.-X., Xing, J.-C., Ren, X., Huang, J., Liao, M., Qi, W., & Huang, L.-H. (2024) · Veterinary Microbiology · doi:10.1016/j.vetmic.2024.110099 · Cited by 7
Liu, S., Zhang, Z., Wang, Z., Li, J., Shen, L., & Wang, X. (2024) · IUBMB Life · doi:10.1002/iub.2855 · Cited by 7
Cha, J. H., Lee, S., Yun, Y., Choi, W. H., Koo, H., Jung, S. H., Chae, H. B., Lee, S. J., Lee, S. J., Jo, D. H., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102257 · Cited by 7
Markley, H. C., Helms, K. J., Maar, M., Zentner, G. E., Wade, M. J., & Zelhof, A. C. (2024) · Journal of Insect Science · doi:10.1093/jisesa/ieae082 · Cited by 7
Liu, Z., Gao, H., Li, G., Yu, Y., Cui, M., Peng, H., Guan, X., Zhang, X., Zhang, Z., Shen, X., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.109234 · Cited by 7
Li, X., Wang, Z., Man, X., Dai, X., Zhou, Q., & Zhang, S. (2025) · Gynecologic Oncology · doi:10.1016/j.ygyno.2025.02.022 · Cited by 7
Structural and dynamic views of the CRISPR-Cas system at the single-molecule level
Lee, S. H., & Bae, S. (2016) · BMB Reports · doi:10.5483/bmbrep.2016.49.4.042 · Cited by 7
O'Shea, P. J., Wildenhain, J., Leveridge, M., Revankar, C. M., Yang, J., Bradley, J., Firth, M. A., Pilling, J. E., Piper, D. R., Chesnut, J. D., et al. (2020) · SLAS DISCOVERY · doi:10.1177/2472555220926160 · Cited by 7
Learning gene networks underlying clinical phenotypes using SNP perturbation
McCarter, C., Howrylak, J. A., & Kim, S.-Y. (2020) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007940 · Cited by 7
Designing libraries for pooled CRISPR functional screens of long noncoding RNAs
Pulido-Quetglas, C., & Johnson, R. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09918-9 · Cited by 7
Therapeutic Applications of the CRISPR-Cas System
Kang, K., Song, Y., Kim, I., & Kim, T. J. (2022) · Bioengineering · doi:10.3390/bioengineering9090477 · Cited by 7
Klee, K. M., Hess, M. W., Lohmüller, M., Herzog, S., Pfaller, K., Müller, T., Vogel, G. F., & Huber, L. A. (2023) · eLife · doi:10.7554/elife.80135 · Cited by 7
Dallo, T., Krishnakumar, R., Kolker, S., & Ruffing, A. M. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00653 · Cited by 7
Targeted CRISPR activation and knockout screenings identify novel doxorubicin transporters
Li, Y., Tan, M., Sun, S., Stea, E., & Pang, B. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00847-0 · Cited by 7
Efficient analysis of mouse genome sequences reveal many nonsense variants
Steeland, S., Timmermans, S., Ryckeghem, S. V., Hulpiau, P., Saeys, Y., MONTAGU, M. V., Vandenbroucke, R. E., & Libert, C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1605076113 · Cited by 7
Kroll, T. C., Schmidt, D., Schwanitz, G., Ahmad, M., Hamann, J., Schlosser, C., Lin, Y., Böhm, K. J., Tuckermann, J. P., & Ploubidou, A. (2016) · Current Protocols in Cytometry · doi:10.1002/cpcy.7 · Cited by 7
Cheng, W., & Lei, X. G. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802168-2.00037-3 · Cited by 7
Advances in CRISPR-Cas based genome engineering
Katrekar, D., Hu, M. Y., & Mali, P. (2017) · Current Opinion in Biomedical Engineering · doi:10.1016/j.cobme.2017.04.001 · Cited by 7
Genome-scale drop-out screens to identify cancer cell vulnerabilities in AML
Basheer, F., & Vassiliou, G. S. (2019) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2019.04.004 · Cited by 7
CRISPR-Cas: Removing Boundaries of the Nature
Cebrailoglu, N., Yildiz, A. B., Akkaya, Ö., & Çiftçi, Y. Ö. (2019) · European Journal of Biology · doi:10.26650/eurjbiol.2019.0024 · Cited by 8
Gubat, J., Selvaraju, K., Sjöstrand, L., Singh, D. K., Turkina, M. V., Schmierer, B., Sabatier, P., Zubarev, R. A., Linder, S. T., & D’Arcy, P. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.852980 · Cited by 7
Disrupting a negative feedback loop drives endocrine therapy-resistant breast cancer
Foulds, C. E. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1811263115 · Cited by 7
Mays, J. C., Alfieri, F., Trifas, M., Kogenaru, M., Quysbertf, H. M., Mei, S., Bosco, N., Zhao, X., Bianchi, J. J., Goldberg, A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.08.555746 · Cited by 7
Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Liu, D., Liu, L., Zhang, X., Zhao, X., Li, X., Che, X., & Wu, G. (2025) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2025.101358 · Cited by 6
Zhang, L.-Y., Yin, H., Wang, Y., Yan, M., Wang, C., Shang, X., Liu, W.-Y., Li, Z., Jia, H., Zhang, Z., et al. (2025) · Communications Biology · doi:10.1038/s42003-025-08670-z · Cited by 6
A small-scale CRISPR mutant library in rapeseed of commercial cultivar Zhongshuang 11
Zeng, C., He, J., Li, J., Fan, S., Wu, M., Cheng, X., Xia, Y., Zhang, D., Dun, X., & Li, M. (2026) · Horticulture Research · doi:10.1093/hr/uhag087 · Cited by 6
Xie, J., & DiMaio, D. (2021) · FEBS Journal · doi:10.1111/febs.15775 · Cited by 6
Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine
Lučanský, V., Holubeková, V., Kolková, Z., Halášová, E., Samec, M., & Golubnitschaja, O. (2023) · The EPMA Journal · doi:10.1007/s13167-023-00324-6 · Cited by 6
Immunomics in one health: understanding the human, animal, and environmental aspects of COVID-19
Gao, J., Zhang, C., Wheelock, Å. M., Xin, S., Cai, H., Xu, L., & Wang, X.-J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1450380 · Cited by 7
Tian, S., Qin, Y., Wu, Y., & Dong, M. (2024) · Nature Protocols · doi:10.1038/s41596-024-01075-y · Cited by 6
Balanced Training Sets Improve Deep Learning-Based Prediction of CRISPR sgRNA Activity
Trivedi, V., Mohseni, A., Lonardi, S., & Wheeldon, I. R. (2024) · ACS Synthetic Biology · doi:10.1021/acssynbio.4c00542 · Cited by 6
Exploring the potential of CRISPR in triple-negative breast cancer treatment
Chakravarty, L., Ahmad, S., Khatun, A., & Khan, S. A. (2024) · Innovative Practice in Breast Health · doi:10.1016/j.ibreh.2024.100028 · Cited by 6
Role of artificial intelligence in cancer detection using protein p53: A Review
Patil, M. R., & Bihari, A. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-10051-4 · Cited by 6
Tan, C., Wang, J., Ye, X., Kasimu, K., Li, Y., Luo, F., Hui, Y., & Luo, Y. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1507163 · Cited by 6
Picking the Survivor! CRISPR Reveals HIV Dependency Factors
Schott, K., & König, R. (2017) · Trends in Microbiology · doi:10.1016/j.tim.2017.02.004 · Cited by 6
Edited course of biomedical research: leaping forward with CRISPR
Collins, P. J., Hale, C. M., & Xu, H. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.09.008 · Cited by 6
Gaining New Insights into Fundamental Biological Pathways by Bacterial Toxin-Based Genetic Screens
Tian, S., & Zhou, N. (2023) · Bioengineering · doi:10.3390/bioengineering10080884 · Cited by 6
Cui, Y.-Z., Xu, F., Zhou, Y., Wang, Z., Yang, X.-Y., Fu, N.-C., Chen, X., Zheng, Y., Chen, X., Ye, L., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.02.018 · Cited by 6
Ramani, V., & Shendure, J. (2016) · Genome biology · doi:10.1186/s13059-016-0905-4 · Cited by 6
Detection of Apoptotic Versus Autophagic Cell Death by Flow Cytometry
Sica, V., Maiuri, M. C., Kroemer, G., & Galluzzi, L. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3581-9_1 · Cited by 6
From transcriptional complexity to cellular phenotypes: Lessons from yeast
Pelechano, V. (2017) · Yeast · doi:10.1002/yea.3277 · Cited by 6
Functional non-homologous end joining patterns triggered by CRISPR/Cas9 in human cells
Yang, F., Ge, X., He, X., Liu, X., Zhou, C., Sun, H., Zhang, J., Zhao, J., Song, Z., Qu, J., et al. (2018) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2018.02.009 · Cited by 6
Hanlon, K. M., Thompson, A., Pantano, L., Hutchinson, J. N., Al‐Obeidi, A., Wang, S., Bliss‐Moreau, M., Helble, J. D., Alexe, G., Stegmaier, K., et al. (2019) · Cancer Genetics · doi:10.1016/j.cancergen.2019.06.003 · Cited by 6
Inwood, S. N., McLaughlin, G. M., Buckley, T. R., Cox, M. P., Handley, K. M., Steeves, T. E., Strabala, T. J., McDougal, R. L., & Dearden, P. K. (2020) · New Zealand Journal of Ecology · doi:10.20417/nzjecol.44.22 · Cited by 6
Reduced gene templates for supervised analysis of scale-limited CRISPR-Cas9 fitness screens
Vinceti, A., Perron, U., Trastulla, L., & Iorio, F. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111145 · Cited by 6
CRISPR/Cas9-Based Positive Screens for Cancer-Related Traits
Slipek, N. J., Varshney, J., & Largaespada, D. A. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8967-6_11 · Cited by 6
CRISPRCloud2: A cloud-based platform for deconvolving CRISPR screen dataPreprint
Jeong, H.-H., Kim, S., Rousseaux, M. W. C., Zoghbi, H. Y., & Liu, Z. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/309302 · Cited by 6
Mouse Models of Myeloid MalignanciesPreprint
Basheer, F., & Vassiliou, G. S. (2020) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a035535 · Cited by 6
Li, C., Fu, J., Shao, S., & Luo, Z. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.31.564884 · Cited by 6
CRISPR/Cas9‐edited tumor‐associated immune cells in cancer immunotherapy
Ma, Y., Chen, J., Du, Y., Cao, Z., Ji, W., Niu, Y., & Yang, Z. (2025) · Open Research (University of Surrey) · doi:10.1002/viw.20250002 · Cited by 5
Xue, C., Zhang, X., Yu, W., Lin, H., Zhang, J., Liu, J., Weng, Z., Ouyang, M., & Lin, X. (2025) · Translational Oncology · doi:10.1016/j.tranon.2025.102423 · Cited by 5
Vahabi, M., Xu, G., Sarkisjan, D., Hassouni, B. E., Mantini, G., Donati, V. L., Wang, B., Lencioni, G., Honeywell, R. J., Deng, D., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-025-03470-z · Cited by 5
Genome-wide CRISPR Screen Identifies Sec31A as a Key Regulator of Alpha Cell Survival
Shibue, K., Kahraman, S., Castillo-Quan, J. I., Jesus, D. F. D., Hu, J. Y., Morita, H., Blackwell, T. K., Peng, Y., & Kulkarni, R. (2025) · Nature Communications · doi:10.1038/s41467-025-64169-5 · Cited by 6
A Rapid, High-Throughput Method for the Construction of Mutagenesis Libraries
Lu, Y., Meng, S., Guan, X., He, P., & Zhao, D. (2025) · Biomolecules · doi:10.3390/biom15111511 · Cited by 5
Bitter, E. E., Skidmore, J. R., Allen, C. I., Erickson, R. I., Morris, R. M., Mortimer, T. O., Meade, A., Brog, R. A., Phares, T., Townsend, M. H., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293128 · Cited by 5
Song, D., Song, C. W., Cho, S. H., Kwon, T. Y., Jung, H., Park, K. H., Kim, J., Seo, J., Yoo, J., Kim, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202406492 · Cited by 5
Pooled CRISPR screens identifies key regulators of bovine stem cell expansion for cultured meat
Zirman, A., El-Nabi, M. A., Samuel, E., Anavy, L., Zohar Yakhini, B., Nachman, I., & Rak, R. (2025) · Communications Biology · doi:10.1038/s42003-025-08760-y · Cited by 5
Viral delivery of genome-modifying proteins for cellular reprogramming
Mikkelsen, J. G. (2018) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2018.06.005 · Cited by 6
The link between menin and pleiotrophin in the tumor biology of pancreatic neuroendocrine neoplasms
Li-ping, H., Boulant, S., Stanifer, M. L., Guo, C., Nießen, A., Chen, M., Felix, K., Bergmann, F., Strobel, O., & Schimmack, S. J. (2022) · Cancer Science · doi:10.1111/cas.15301 · Cited by 5
Tudose, C., Bond, J., & Ryan, C. J. (2023) · NAR Cancer · doi:10.1093/narcan/zcad056 · Cited by 5
Zhu, H., Chen, H., Zhu, X., Zhang, B., & Jin, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1462512 · Cited by 5
Jang, M., Lee, S.-H., & Kim, J. (2025) · Springer eBooks · doi:10.1007/978-981-97-7395-4_5 · Cited by 5
The Estrogen-Regulated Transcriptome: Rapid, Robust, Extensive, and Transient
Vasquez, Y. M., & Kraus, W. L. (2018) · Cancer drug discovery and develogment/Cancer drug discovery and development · doi:10.1007/978-3-319-99350-8_5 · Cited by 5
Microarray Filtering-Based Fuzzy C-Means Clustering and Classification in Genomic Signal Processing
Mishra, P., & Bhoi, N. (2019) · Arabian Journal for Science and Engineering · doi:10.1007/s13369-019-03945-0 · Cited by 5
Hypothesis-driven science in large-scale studies: the case of GWAS
Read, J. A. M., & Sharma, S. (2021) · Biology & Philosophy · doi:10.1007/s10539-021-09823-0 · Cited by 5
nuPRISM: Microfluidic Genome-Wide Phenotypic Screening Platform for Cellular Nuclei
Abdrabou, A. M., Duong, B. T. V., Chen, K., Atwal, R. S., Labib, M., Lin, S., Angers, S., & Kelley, S. O. (2022) · ACS Central Science · doi:10.1021/acscentsci.2c00836 · Cited by 5
Back to the Future: Mutant Hunts Are Still the Way To Go
Winston, F., & Koshland, D. E. (2016) · Genetics · doi:10.1534/genetics.115.180596 · Cited by 5
Illuminating the structure and dynamics of chromatin by fluorescence labeling
Shao, S., Chang, L., Hou, Y., & Sun, Y. (2017) · Frontiers in Biology · doi:10.1007/s11515-017-1454-2 · Cited by 5
Genetically Modified Animal Models
Chaible, L. M., Kinoshita, D., Corat, M. A. F., & Dagli, M. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809468-6.00027-9 · Cited by 5
Modern Tools for Detection and Diagnosis of Plant Pathogens
Kunta, M., Park, J., Braswell, W. E., da Graça, J. V., & Edwards, P. (2020) · Springer eBooks · doi:10.1007/978-981-15-6275-4_4 · Cited by 5
Genome Editing in Medicinal Plants Using CRISPR/Cas9 Tool
Naik, B. J., Vasamsetti, B. M. K., Kim, S., Mallikarjuna, G., Swamy, M. K., & Mekapogu, M. (2022) · Springer eBooks · doi:10.1007/978-981-19-5779-6_23 · Cited by 5
Decoding directional genetic dependencies through orthogonal CRISPR/Cas screensPreprint
Boettcher, M., Tian, R., Blau, J. A., Markegard, E., Wu, D., Biton, A., Zaitlen, N., McCormick, F. P., Kampmann, M., & McManus, M. T. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/120170 · Cited by 5
Mapping in vivo genetic interactomics through Cpf1 crRNA array screeningPreprint
Chow, R. D.-W., Wang, G., Codina, A., Ye, L., & Chen, S. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/153486 · Cited by 5
Head and gaze tracking of unrestrained marmosetsPreprint
Turesson, H., Conceição, T. B. R., & Ribeiro, S. T. G. (2016) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/079566 · Cited by 5
Cas12a/Cpf1 knock-in mice enable efficient multiplexed immune cell engineeringPreprint
Dong, M. B., Tang, K., Zhou, X., Shen, J., Chen, K., Kim, H. R., Zhou, J., Cao, H., Vandenbulcke, E., Zhang, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.14.532657 · Cited by 5
Cosseboom, S. D., Agarwal, C., & Hu, M. (2023) · Frontiers in Plant Science · doi:10.3389/fpls.2023.1278133 · Cited by 5
Gastric Organoid, a Promising Modeling for Gastric Stem Cell Homeostasis and Therapeutic Application
Lee, S., Choi, J.-H., Park, S., & Kim, J. (2024) · International Journal of Stem Cells · doi:10.15283/ijsc23075 · Cited by 4
CRISPR-Cas9 in Functional Genomics: Implications for Target Validation in Precision Oncology
–Hussien, I. F. A., Alkhalidi, M. H. O., Al-Musawi, S., Al-Shalah, L. A. M., & Sheykhhasan, M. (2025) · Trends in Pharmaceutical Biotechnology · doi:10.57238/tpb.2025.153196.1026 · Cited by 4
Thavorasak, T., Santajit, S., Tunyong, W., Kong-Ngoen, T., Reamtong, O., Ampawong, S., Saelim, N., Srisai, T., Aiumurai, P., Pumirat, P., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0329638 · Cited by 4
Multiplexed perturbation enables scalable pooled screens
Oberlin, S., Tay, N. Q., Xue, A., Mosadeghi, R., Pimentel, H., & McManus, M. T. (2026) · Nature Methods · doi:10.1038/s41592-026-03095-w · Cited by 4
Castellano, K. R., Manner, C. J., Kellogg, R. M., McAtee, R. M., Capozzi, N. M., Wray, G. A., & Bodnar, A. G. (2025) · Communications Biology · doi:10.1038/s42003-025-08890-3 · Cited by 4
Chen, Y., Duan, Q., Wang, L., He, Q., Fang, L., Xiao, L., Song, H., & Cao, Y. (2025) · Trends in biotechnology · doi:10.1016/j.tibtech.2025.10.005 · Cited by 4
Emerging hallmarks and the rise of complexities and heterogeneity of tumor
Arora, H. L., Sekar, G., Phadnis, A., Bahot, A., Bomle, D., Patel, V. G., Pal, J. K., Sarode, S. C., & Sharma, N. K. (2025) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2025.102347 · Cited by 4
Mengistu, G. (2026) · The Journal of Gene Medicine · doi:10.1002/jgm.70091 · Cited by 4
Overview of Cancer Genomics, Organization, and Variations in the Human Genome
Yamin, M., Raza, H. G., & Fatima, I. (2020) · Springer eBooks · doi:10.1007/978-981-15-1067-0_1 · Cited by 4
Barlan, K., Bhide, G. P., White, D. R., Lake, M. R., Lu, C., Rieder, S., Fan, L., & Hsieh, C.-L. (2023) · SLAS DISCOVERY · doi:10.1016/j.slasd.2023.10.004 · Cited by 4
Barriga, F. M., & Lowe, S. W. (2024) · Nature Protocols · doi:10.1038/s41596-024-00953-9 · Cited by 4
Yu, S., Tong, L.-W., Shen, J., Li, C., Hu, Y., Feng, K.-K., & Shao, J. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116290 · Cited by 4
Guo, Z., Wang, S., Wang, Y., Wang, Z., & Ou, G. (2024) · PLoS Genetics · doi:10.1371/journal.pgen.1011377 · Cited by 4
Deciphering the role of LncRNA in alcoholic liver disease: Mechanisms and therapeutic potential
Zhang, L., Wang, R., Nan, Y., & Kong, L. (2024) · Medicine · doi:10.1097/md.0000000000040378 · Cited by 4
GO-CRISPR: A highly controlled workflow to discover gene essentiality in loss-of-function screens
Perampalam, P., McDonald, J. I., & Dick, F. A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0315923 · Cited by 4
Du, Y., Yang, Y., Zheng, B., Zhang, Q., Zhou, S., & Zhao, L. (2025) · Oncogene · doi:10.1038/s41388-025-03273-8 · Cited by 4
Li, H., Song, C., Li, Y., Zhang, T., Yang, X., & Wang, H. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.140728 · Cited by 4
High-throughput CRISPR approaches: New solutions for challenging problems
Bindal, G., Misra, C. S., Singh, M. K., Rangu, S. S., Pandey, N., & Rath, D. (2025) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2025.118245 · Cited by 4
Metadata
- Authors
- Shalem, O., Sanjana, N. E., & Zhang, F.
- Affiliations
- Broad Institute (US)
- Corresponding author
- Shalem, Ophir
- Zhang, Feng
- Venue
- Nature Reviews Genetics
- Published
- 2015-04-09
- Volume
- 16
- Issue
- 5
- Pages
- 299-311
- ISSN
- 1471-0056 (ISSN-L)
- 1471-0064
- PMC
- PMC4503232
- OpenAlex
- W2026592619
- Cited by
- 1,233
- References
- 130
- Citations by year
- 2026: 71 · 2025: 91 · 2024: 103 · 2023: 85 · 2022: 101 · 2021: 105 · 2020: 121 · 2019: 117 · 2018: 131 · 2017: 145 · 2016: 123 · 2015: 37
- FWCI
- 14.12
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature Reviews Genetics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
- PMC
- Funders
- Klarman Family Foundation
- Simons Center for the Social Brain, Massachusetts Institute of Technology
- National Institute of Mental Health (DP1MH100706)
- National Human Genome Research Institute (K99HG008171)
- National Institute of Neurological Disorders and Stroke (R01NS073124)
- National Center for Chronic Disease Prevention and Health Promotion (DP1‑MH100706)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- CRISPR/Cas9, genome-wide screen, guide RNA library, forward genetic screen, gene knockout, transcriptional regulation, phenotypic screening, screen design, functional genomics
- MeSH terms
- Animals, Genetic Testing, Humans, Models, Genetic, Gene Library, Genomics, RNA Interference, Mice, Gene Knockout Techniques, High-Throughput Nucleotide Sequencing, CRISPR-Cas Systems
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review